IAMIambic Therapeutics
AI驱动的临床阶段生物技术公司,整合大规模AI与自动化化学/生物学实验平台。
$16发行价
$150M融资额
$18.91首日收盘
18.19%首日表现
AI驱动的临床阶段生物技术公司,整合大规模AI与自动化化学/生物学实验平台。
公司简介(来源:StockAnalysis)
Iambic Therapeutics is a technology and clinical-stage life sciences company pursuing a fundamental shift in the biopharmaceutical industry. Our mission is to make better technology for better medicines. We do this by integrating leading proprietary, large-scale artificial intelligence (AI) with automated, scalable chemistry and biology experimentation. We call this approach molecular superintelligence. Instead of treating each stage of drug discovery as a distinct technological challenge, we have developed a unified, intelligent platform desig...
51CFO 判断:需精通AI制药资本化路径、研发费用资本化准则及生物科技IPO财务建模的CFO。
管理层与创始团队详情以 SEC 招股书披露为准
你的公司需要这样的 CFO 吗?
51CFO 为你匹配完整经历过美股 IPO 全过程的欧美籍 CFO 及其他 C 级高管。首批人选 48 小时内可见,免费 30 分钟上市人才诊断,24 小时内回复。
预约咨询